Ganglioside antigens expressed by human cancer cells Journal Article


Authors: Ritter, G.; Livingston, P. O.
Article Title: Ganglioside antigens expressed by human cancer cells
Abstract: Gangliosides are normal cell surface components of all animal cells. Altered ganglioside biosynthesis during malignant transformation results in expression of a qualitatively and quantitatively different ganglioside profile in many tumors. While their physiological function is largely unclear, gangliosides expressed by cancer cells, e.g. GD3, GD2 and GM2 in malignant melanoma, have proven to be suitable targets for passive immunotherapy with monoclonal antibodies and for active immunotherapy with vaccines. Studies aimed at further augmenting the effectiveness of these approaches are currently underway. © 1991 Academic Press Ltd.
Keywords: review; molecular genetics; neoplasm; neoplasms; mouse; animal; metabolism; mice; melanoma; tumor antigen; monoclonal antibody; biosynthesis; immunology; antibodies, monoclonal; chemistry; molecular sequence data; antigen; immunotherapy; antigens; antigens, neoplasm; chemical structure; molecular structure; tumor vaccine; carbohydrate analysis; carbohydrate sequence; glycosphingolipid; gangliosides; ganglioside; human; support, non-u.s. gov't; ganglioside, gd3
Journal Title: Seminars in Cancer Biology
Volume: 2
Issue: 6
ISSN: 1044-579X
Publisher: Academic Press Inc., Elsevier Science  
Date Published: 1991-12-01
Start Page: 401
End Page: 409
Language: English
PUBMED: 1810468
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Citation Impact
MSK Authors
  1. Gerd Ritter
    166 Ritter